Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.


Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.

 

"Pain. Joints. Spine." Том 9, №1, 2019

Back to issue

Vitamin D Supplementation Guidelines for General Population and Groups at Risk of Vitamin D Deficiency in Poland

Authors: Agnieszka Rusińska (1), Paweł Płudowski (2), Mieczysław Walczak (3), Maria K. Borszewska-Kornacka (4), Artur Bossowski (5), Danuta Chlebna-Sokół (1), Justyna Czech-Kowalska (6), Anna Dobrzańska (6), Edward Franek (7), Ewa Helwich (8), Teresa Jackowska (9), Maria A. Kalina (10), Jerzy Konstantynowicz (11), Janusz Książyk (12), Andrzej Lewiński (13), Jacek Łukaszkiewicz (14), Ewa Marcinowska-Suchowierska (15), Artur Mazur (16), Izabela Michałus (1), Jarosław Peregud-Pogorzelski (17), Hanna Romanowska (3), Marek Ruchała (18), Piotr Socha (19), Mieczysław Szalecki (20, 21), Mirosław Wielgoś (22), Danuta Zwolińska (23) and Arkadiusz Zygmunt (13)

Categories: Rheumatology, Traumatology and orthopedics

Sections: Clinical researches

print version

Рекомендації Польської асоціації педіатричної ендокринології й діабету,
Експертної групи за участі національних консультантів та представників
наукових асоціацій: редакція 2018 р.

Вступ

Кальцитріол [1,25-дигідроксихолекальциферол (1,25(OH)2D)] є активною (гормональною) формою вітаміну D. За своєю дією він належить до широкої групи гормональних речовин, транскрипційних факторів генів білків-мішеней. На відміну від інших гормонів, що належать до цієї групи (андрогенів, естрогенів, глюкокортикоїдів, мінералокортикоїдів та прогестерону), синтез кальцитріолу обмежується наявністю/відсутністю його субстрату, 25-гідроксивітаміну D (25(OH)D). 25(OH)D є найбільш поширеним метаболітом вітаміну D. Його концентрація в сироватці крові визначає статус вітаміну D в організмі. Тому вітамін D ...


For the full article you need to subscribe to the magazine.


Bibliography

1. Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord (2017) 18(2):153–65.10.1007/s11154-017-9424-1 [PubMed] [CrossRef]
2. Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr (2016) 103(4):1033–44.10.3945/ajcn.115.120873 [PMC free article] [PubMed] [CrossRef]
3. Spiro A, Buttriss JL. Vitamin D: an overview of vitamin D status and intake in Europe. Nutr Bull (2014) 39:322–50.10.1111/nbu.12108 [PMC free article] [PubMed] [CrossRef]
4. Sewerynek E, Cieślak K, Janik M, Gowin E, Stuss M. Evaluation of vitamin D concentration in a po–pulation of young, healthy women – the effects of vitamin D supplementation. Endokrynol Pol (2017) 68(5):533–40.10.5603/EP.a2017.0042 [PubMed] [CrossRef]
5. Łupińska A, Chlebna-SokóŁ D. Czynniki wpŁywajace na stężenie witaminy D w surowicy dzieci Łódzkich w wieku wczesnoszkolnym z nadmiarem masy ciaŁa. Post N Med (2016) XXIX(10):709–15.
6. Chlebna-SokóŁ D, MichaŁus I, Rusińska A, Łupińska A, FijaŁkowski B, Andrzejewska K, et al. Ocena stężenia witaminy D w surowicy u dzieci hospitalizowanych z powodu objawów klinicznych sugerujacych zaburzenia w ukŁadzie kostnym. Endokrynologia Pediatryczna (2016) 15.4.57:23–32.
7. PŁudowski P, Ducki C, Konstantynowicz J, Jaworski M. Vitamin D status in Poland. Pol Arch Med Wewn (2016) 126(7–8):530–9.10.20452/pamw.3479 [PubMed] [CrossRef]
8. Munns CF, Shaw N, Kiely M, Specker BL, Tha–cher TD, Ozono K, et al.Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab (2016) 101(2):394–415.10.1210/jc.2015-2175 [PMC free article] [PubMed] [CrossRef]
9. PŁudowski P, Karczmarewicz E, Bayer M, Car–ter G, Chlebna-SokóŁ D, Czech-Kowalska J, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol (2013) 64(4):319–27.10.5603/EP.2013.0012 [PubMed] [CrossRef]
10. Charzewska J, Chlebna-SokóŁ D, Chybicka A, Czech-Kowalska J, Dobrzańska A, Helwich E, et al. Prophylaxis of vitamin D deficiency – polish recommendation 2009. Ginekol Pol (2010) 81(2):149–53. [PubMed]
11. Kunachowicz H, Nadolna I, Przygoda B. i wsp.: Tabele skŁadu i wartości odżywczej żywności. Warszawa: Wydawnictwo Lekarskie PZWL; (2005).
12. Krzyścin JW, Guzikowski J, Rajewska-Więch B. Optimal vitamin D3 daily intake of 2000IU inferred from modeled solar exposure of ancestral humans in Northern Tanzania. J Photochem Photobiol B (2016) 159:101–5.10.1016/j.jphotobiol.2016.03.029 [PubMed] [CrossRef]
13. Krzyścin JW, JarosŁawski J, Sobolewski PS. A mathematical model for seasonal variability of vitamin D due to solar radiation. J Photochem Photobiol B (2011) 105(1):106–12.10.1016/j.jphotobiol.2011.07.008 [PubMed] [CrossRef]
14. Łukaszkiewicz J. Vitamin D – skin synthesis revisited. Nowe spojrzenie na syntezę skórna witaminy D. Post N Med (2016) XXIX(10):747–9.
15. Bogaczewicz J, Karczmarewicz E, Pludowski P, Zabek J, Wozniacka A. Requirement for vitamin D supplementation in patients using photoprotection: variations in vitamin D levels and bone formation markers. Int J Dermatol (2016) 55(4):e176–83.10.1111/ijd.13024 [PubMed] [CrossRef]
16. Aghajafari F, Field CJ, Kaplan BJ, Rabi DM, Maggiore JA, O’Beirne M, et al. The current recommended vitamin D intake guideline for diet and supplements during pregnancy is not adequate to achieve vitamin D sufficiency for most pregnant women. PLoS One (2016) 11(7):e0157262.10.1371/journal.pone.0157262 [PMC free article] [PubMed] [CrossRef]
17. Cashman KD, van den Heuvel EG, Schoema–ker RJ, Prévéraud DP, Macdonald HM, Arcot J. 25-hydroxyvitamin D as a biomarker of vitamin D status and its modeling to inform strategies for prevention of vitamin D deficiency within the population. Adv Nutr (2017) 8(6):947–57.10.3945/an.117.015578 [PMC free article] [PubMed] [CrossRef]
18. Kalina M, MaŁecka-Tendera E. Zaburzenia gospodarki wapniowo-fosforanowej. In: Milewicz A, editor.  Endokrynologia kliniczna. WrocŁaw: Wydawnictwo Polskie Towarzystwo Endokrynologiczne (2012). p. 279–96.
19. Czech-Kowalska J, Latka-Grot J, Bulsiewicz D, Jaworski M, Pludowski P, Wygledowska G, et al. Impact of vitamin D supplementation during lactation on vitamin D status and body composition of mother-infant pairs: a MAVID randomized controlled trial. PLoS One (2014) 9(9):e107708.10.1371/journal.pone.0107708 [PMC free article] [PubMed] [CrossRef]
20. Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev (2014) 4:CD000227.10.1002/14651858.CD000227.pub4 [PubMed] [CrossRef]
21. Lu RJ, Zhu SM, Tang FL, Zhu XS, Fan ZD, Wang GL, et al. Effects of vitamin D or its analogues on the mortality of patients with chronic kidney disease: an updated systematic review and meta-analysis. Eur J Clin Nutr (2017) 71(6):683–93.10.1038/ejcn.2017.59 [PubMed] [CrossRef]
22. Mazzaferro S, Goldsmith D, Larsson TE, Massy ZA, Cozzolino M. Vitamin D metabolites and/or analogs: which D for which patient? Curr Vasc Pharmacol (2014) 12(2):339–49.10.2174/15701611113119990024 [PubMed] [CrossRef]
23. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci (2004) 29(12):664–73.10.1016/j.tibs.2004.10.005 [PubMed] [CrossRef]
24. Jones G, Kottler ML, Schlingmann KP. Genetic diseases of vitamin D metabolizing enzymes. Endocrinol Metab Clin North Am (2017) 46(4):1095–117.10.1016/j.ecl.2017.07.011 [PubMed] [CrossRef]
25. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med (2011) 365(5):410–21.10.1056/NEJMoa1103864 [PubMed] [CrossRef]
26. Pronicka E, Ciara E, Halat P, Janiec A, Wójcik M, Rowińska E, et al. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases. J Appl Genet (2017) 58(3):349–53.10.1007/s13353-017-0397-2 [PMC free article] [PubMed] [CrossRef]
27. Anderson PH. Vitamin D activity and metabolism in bone. Curr Osteoporos Rep (2017) 15(5):443–9.10.1007/s11914-017-0394-8 [PubMed] [CrossRef]
28. Piri F, Khosravi A, Moayeri A, Moradipour A, Derakhshan S. The effects of dietary supplements of calcium, vitamin D and estrogen hormone on serum levels of OPG and RANKL cytokines and their relationship with increased bone density in rats. J Clin Diagn Res (2016) 10(9):AF01–04. [PMC free article] [PubMed]
29. Basatemur E, Sutcliffe A. Incidence of hypocalcemic seizures due to vitamin D deficiency in children in the United Kingdom and Ireland. J Clin Endocrinol Metab (2015) 100(1):E91–5.10.1210/jc.2014-2773 [PubMed] [CrossRef]
30. Vuletić B, Marković S, Igrutinović Z, Vladimir R, Rasković Z, Simović A. Case report of an infant with severe vitamin D deficiency rickets manifested as hypocalcemic seizures. Srp Arh Celok Lek (2016) 144(1–2):90–3.10.2298/SARH1602090V [PubMed] [CrossRef]
31. Pedrosa C, Ferraria N, Limbert C, Lopes L. Hypovitaminosis D and severe hypocalcaemia: the rebirth of an old disease. BMJ Case Rep (2013).10.1136/bcr-2012-007406 [PMC free article] [PubMed] [CrossRef]
32. Ariganjoye R. Pediatric hypovitaminosis D: molecular perspectives and clinical implications. Glob Pediatr Health (2017) 4:2333794X16685504.10.1177/2333794X16685504 [PMC free article][PubMed] [CrossRef]
33. Bhattoa HP, Konstantynowicz J, Laszcz N, Wojcik M, Pludowski P. Vitamin D: musculoskeletal health. Rev Endocr Metab Disord (2017) 18(3):363–71.10.1007/s11154-016-9404-x [PubMed] [CrossRef]
34. Dawson-Hughes B. Vitamin D and muscle function. J Steroid Biochem Mol Biol (2017) 173:313–6.10.1016/j.jsbmb.2017.03.018 [PubMed] [CrossRef]
35. Glackin S, Mayne P, Kenny D, McMahon CJ, Cody D. Dilated cardiomyopathy secondary to vitamin D deficiency and hypocalcaemia in the Irish paediatric population: a case report. Ir Med J (2017) 110(3):535. [PubMed]
36. Bansal B, Bansal M, Bajpai P, Garewal HK. Hypocalcemic cardiomyopathy-different mechanisms in adult and pediatric cases. J Clin Endocrinol Metab (2014) 99(8):2627–32.10.1210/jc.2013-3352 [PubMed] [CrossRef]
37. Högler W. Complications of vitamin D deficiency from the foetus to the infant: one cause, one prevention, but who’s responsibility? Best Pract Res Clin Endocrinol Metab (2015) 29(3):385–98.10.1016/j.beem.2015.03.003 [PubMed] [CrossRef]
38. Marshall Brinkley D, Ali OM, Zalawadiya SK, Wang TJ. Vitamin D and heart failure. Curr Heart Fail Rep (2017) 14(5):410–20.10.1007/s11897-017-0355-7 [PubMed] [CrossRef]
39. Grant WB, Wimalawansa SJ, Holick MF, Cannell JJ, Pludowski P, Lappe JM, et al. Emphasizing the health benefits of vitamin D for those with neurodeve–lopmental disorders and intellectual disabilities. Nutrients (2015) 7(3):1538–64.10.3390/nu7031538 [PMC free article] [PubMed] [CrossRef]
40. Shroff R, Knott C, Gullett A, Wells D, Marks SD, Rees L. Vitamin D deficiency is associated with short stature and may influence blood pressure control in paediatric renal transplant recipients. Pediatr Nephrol (2011) 26(12):2227–33.10.1007/s00467-011-1920-z [PubMed] [CrossRef]
41. Larner DP, Adams JS, Hewison M. Regulation of renal and extrarenal 1α-hydroxylase. 4th ed. In: Feldman D, Pike JW, Bouillon R, Giovannucci E, Goltzman D, Hewison M, editors. Vitamin D. London: Academic Press (Elsevier) (2018). p. 117–37.
42. Marcinowska-Suchowierska A, PŁudowski P. Vitamin D toxicity. Zatrucie witamina D. Post N Med (2016) XXIX(10):756–9.
43. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: a pleiotropic hormone. Kidney Int (2010) 78(2):140–5.10.1038/ki.2010.17 [PubMed] [CrossRef]
44. Deschasaux M, Souberbielle JC, Partula V, Lécuyer L, Gonzalez R, Srour B, et al. What do people know and believe about vitamin D? Nutrients (2016) 8(11):E718.10.3390/nu8110718 [PMC free article] [PubMed] [CrossRef]
45. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev (2010) 9(11):709–15.10.1016/j.autrev.2010.06.009 [PubMed] [CrossRef]
46. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality - a review of recent evidence. Autoimmun Rev (2013) 12(10):976–89.10.1016/j.autrev.2013.02.004 [PubMed] [CrossRef]
47. Carlberg C. Molecular endocrinology of vitamin D on the epigenome level. Mol Cell Endocrinol (2017) 453:14–21.10.1016/j.mce.2017.03.016 [PubMed] [CrossRef]
48. Carlberg C, Haq A. The concept of the perso–nal vitamin D response index. J Steroid Biochem Mol Biol (2018) 175:12–7.10.1016/j.jsbmb.2016.12.011 [PubMed] [CrossRef]
49. Wu W, Beilhartz G, Roy Y, Richard CL, Curtin M, Brown L, et al.Nuclear translocation of the 1,25D3-MARRS (membrane associated rapid response to steroids) receptor protein and NFkappaB in differentiating NB4 leukemia cells. Exp Cell Res (2010) 316(7):1101–8.10.1016/j.yexcr.2010.01.010 [PubMed] [CrossRef]
50. Khanal R, Nemere I. Membrane receptors for vitamin D metabolites. Crit Rev Eukaryot Gene Expr (2007) 17(1):31–47.10.1615/CritRevEukarGeneExpr.v17.i1.30 [PubMed] [CrossRef]
51. Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol (2014) 5:151.10.3389/fphys.2014.00151 [PMC free article][PubMed] [CrossRef]
52. Díaz L, Díaz-Muñoz M, García-Gaytán AC, Mén–dez I. Mechanistic effects of calcitriol in cancer biology. Nutrients (2015) 7(6):5020–50.10.3390/nu7065020 [PMC free article] [PubMed] [CrossRef]
53. Abu El Maaty MA, Wölfl S. Vitamin D as a no–vel regulator of tumor metabolism: insights on potential mechanisms and implications for anti-cancer therapy. Int J Mol Sci (2017) 18(10):E2184.10.3390/ijms18102184 [PMC free article] [PubMed] [CrossRef]
54. Rode AKO, Kongsbak M, Hansen MM, Lopez DV, Levring TB, Woetmann A, et al. Vitamin D counteracts Mycobacterium tuberculosis-induced cathelicidin downregulation in dendritic cells and allows Th1 differentiation and IFNγ secretion. Front Immunol (2017) 8:656.10.3389/fimmu.2017.00656 [PMC free article] [PubMed] [CrossRef]
55. Han JE, Alvarez JA, Jones JL, Tangpricha V, Brown MA, Hao L, et al. Impact of high-dose vitamin D3 on plasma free 25-hydroxyvitamin D concentrations and antimicrobial peptides in critically ill mechanically ventilated adults. Nutrition (2017) 38:102–8.10.1016/j.nut.2017.02.002 [PMC free article] [PubMed] [CrossRef]
56. Stukes TM, Shary JR, Wei W, Ebeling MD, Dezsi KB, Shary FS, et al. Circulating cathelicidin concentrations in a cohort of healthy children: influence of age, body composition, gender and vitamin D status. PLoS One(2016) 11(5):e0152711.10.1371/journal.pone.0152711 [PMC free article][PubMed] [CrossRef]
57. Grant WB, Karras SN, Bischoff-Ferrari HA, Annweiler C, Boucher BJ, Juzeniene A, et al. Do studies reporting ‘U’-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects? Dermatoendocrinol (2016) 8(1):e1187349.10.1080/19381980.2016.1187349 [PMC free article] [PubMed] [CrossRef]
58. Martineau AR, Cates CJ, Urashima M, Jensen M, Griffiths AP, Nurmatov U, et al. Vitamin D for the management of asthma. Cochrane Database Syst Rev (2016) 9:CD011511.10.1002/14651858.CD011511.pub2 [PubMed] [CrossRef]
59. Carrara D, Bruno RM, Bacca A, Taddei S, Duranti E, Ghiadoni L, et al. Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosis D. J Hypertens (2016) 34(11):2199–205.10.1097/HJH.0000000000001072 [PubMed] [CrossRef]
60. Grübler MR, Gaksch M, Kienreich K, Verheyen N, Schmid J, Ó Hartaigh BW, et al. Effects of vitamin D supplementation on plasma aldosterone and renin - a randomized placebo-controlled trial. J Clin Hypertens (Greenwich) (2016) 18(7):608–13.10.1111/jch.12825 [PubMed] [CrossRef]
61. Santoro D, Pellicanò V, Cernaro V, Lacava V, Lacquaniti A, Atteritano M, et al. Role of vitamin D in vascular complications and vascular access outcome in patients with chronic kidney disease. Curr Med Chem (2016) 23(17):1698–707.10.2174/0929867323666160405112019 [PubMed] [CrossRef]
62. Chiang KC, Chen TC. The anti-cancer actions of vitamin D. Anticancer Agents Med Chem (2013) 13(1):126–39.10.2174/187152013804487443 [PubMed] [CrossRef]
63. Bandera Merchan B, Morcillo S, Martin-Nuñez G, Tinahones FJ, Macías-González M. The role of vitamin D and VDR in carcinogenesis: through epidemiology and basic sciences. J Steroid Biochem Mol Biol (2017) 167:203–18.10.1016/j.jsbmb.2016.11.020 [PubMed] [CrossRef]
64. Wong MS, Leisegang MS, Kruse C, Vogel J, Schürmann C, Dehne N, et al. Vitamin D promotes vascular regeneration. Circulation (2014) 130(12):976–86.10.1161/CIRCULATIONAHA.114.010650 [PubMed] [CrossRef]
65. Lim K, Lu TS, Molostvov G, Lee C, Lam FT, Zehnder D, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation (2012) 125(18):2243–55.10.1161/CIRCULATIONAHA.111.053405 [PubMed] [CrossRef]
66. Cianciolo G, Capelli I, Angelini ML, Valentini C, Baraldi O, Scolari MP, et al. Importance of vascular calcification in kidney transplant recipients. Am J Nephrol (2014) 39(5):418–26.10.1159/000362492 [PubMed] [CrossRef]
67. Hou YC, Liu WC, Zheng CM, Zheng JQ, Yen TH, Lu KC. Role of vitamin D in uremic vascular calcification. Biomed Res Int (2017) 2017:2803579.10.1155/2017/2803579 [PMC free article] [PubMed] [CrossRef]
68. Annweiler C, Beauchet O. Vitamin D-mentia: randomized clinical trials should be the next step. Neuroepi–emiology (2011) 37(3–4):249–58.10.1159/000334177 [PubMed] [CrossRef]
69. Mpandzou G, Aït Ben Haddou E, Regragui W, Benomar A, Yahyaoui M. Vitamin D deficiency and its role in neurological conditions: a review. Rev Neurol (Paris) (2016) 172(2):109–22.10.1016/j.neurol.2015.11.005 [PubMed] [CrossRef]
70. Berchtold L, Ponte B, Moll S, Hadaya K, Seyde O, Bachtler M, et al. Phosphocalcic markers and calcification propensity for assessment of interstitial fibrosis and vascular lesions in kidney allograft recipients. PLoS One (2016) 11(12):e0167929.10.1371/journal.pone.0167929 [PMC free article] [PubMed] [CrossRef]
71. Arfian N, Muflikhah K, Soeyono SK, Sari DC, Tranggono U, Anggorowati N, et al. Vitamin D attenuates kidney fibrosis via reducing fibroblast expansion, inflammation, and epithelial cell apoptosis. Kobe J Med Sci (2016) 62(2):E38–44. [PMC free article] [PubMed]
72. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science (1980) 209(4458):823–5.10.1126/science.6250216 [PubMed] [CrossRef]
73. Bivona G, Agnello L, Ciaccio M. Vitamin D and immunomodulation: is it time to change the refe–rence values? Ann Clin Lab Sci (2017) 47(4):508–10. [PubMed]
74. Dimitrakopoulou VI, Tsilidis KK, Haycock PC, Dimou NL, Al-Dabhani K, Martin RM, et al. Circulating vitamin D concentration and risk of seven cancers: mendelian randomisation study. BMJ (2017) 359:j4761.10.1136/bmj.j4761 [PMC free article] [PubMed] [CrossRef]
75. Garland C, Gorham E, Garland F. Vitamin D for cancer prevention: global perspective. Ann Epidemiol (2009) 19:468–83.10.1016/j.annepidem.2009.03.021 [PubMed] [CrossRef]
76. Moukayed M, Grant WB. The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: a review of the epidemiology, clinical trials, and mechanisms. Rev Endocr Metab Disord (2017) 18(2):167–82.10.1007/s11154-017-9415-2 [PubMed] [CrossRef]
77. Giovannucci E. Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol (2008) 624:31–42.10.1007/978-0-387-77574-6_3 [PubMed] [CrossRef]
78. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta-analysis. Am J Prev Med (2007) 32(3):210–6.10.1016/j.amepre.2006.11.004 [PubMed] [CrossRef]
79. Vanherwegen AS, Gysemans C, Mathieu C. Regu–lation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin North Am (2017) 46(4):1061–94.10.1016/j.ecl.2017.07.010 [PubMed] [CrossRef]
80. Manousaki D, Dudding T, Haworth S, Hsu YH, Liu CT, Medina-Gómez C, et al. Low-frequency synony–mous coding variation in CYP2R1 has large effects on vitamin D levels and risk of multiple sclerosis. Am J Hum Genet(2017) 101(2):227–38.10.1016/j.ajhg.2017.06.014 [PMC free article][PubMed] [CrossRef]
81. Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, et al. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology (2017) 88(17):1623–9.10.1212/WNL.0000000000003849 [PMC free article] [PubMed] [CrossRef]
82. Rhead B, Bäärnhielm M, Gianfrancesco M, Mok A, Shao X, Quach H, et al. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol Genet (2016) 2(5):e97.10.1212/NXG.0000000000000097 [PMC free article] [PubMed] [CrossRef]
83. Wolsk HM, Chawes BL, Litonjua AA, Hollis BW, Waage J, Stokholm J, et al. Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheeze in early childhood: a combined analysis of two randomized controlled trials. PLoS One (2017) 12(10):e0186657.10.1371/journal.pone.0186657 [PMC free article][PubMed] [CrossRef]
84. Jolliffe DA, Greenberg L, Hooper RL, Griffiths CJ, Camargo CA, Jr, Kerley CP, et al. Vitamin D supplementation to prevent asthma exacerbations: a syste–matic review and meta-analysis of individual participant data. Lancet Respir Med (2017) 5(11):881–90.10.1016/S2213-2600(17)30306-5 [PMC free article] [PubMed] [CrossRef]
85. Kabbani TA, Koutroubakis IE, Schoen RE, Ramos-Rivers C, Shah N, Swoger J, et al. Association of vitamin D level with clinical status in inflammatory bowel disease: a 5-year longitudinal study. Am J Gastroenterol (2016) 111(5):712–9.10.1038/ajg.2016.53 [PubMed] [CrossRef]
86. Meckel K, Li YC, Lim J, Kocherginsky M, Weber C, Almoghrabi A, et al. Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis. Am J Clin Nutr (2016) 104(1):113–20.10.3945/ajcn.115.123786 [PMC free article][PubMed] [CrossRef]
87. Shoenfeld Y, Giacomelli R, Azrielant S, Berardicurti O, Reynolds JA, Bruce IN. Vitamin D and systemic lupus erythematosus – the hype and the hope. Autoimmun Rev (2018) 17(1):19–23.10.1016/j.autrev.2017.11.004 [PubMed] [CrossRef]
88. Eloi M, Horvath DV, Ortega JC, Prado MS, Andrade LE, Szejnfeld VL, et al. 25-hydroxivitamin D serum concentration, not free and bioavailable vitamin D, is associated with disease activity in systemic lupus erythematosus patients. PLoS One (2017) 12(1):e0170323.10.1371/journal.pone.0170323 [PMC free article] [PubMed] [CrossRef]
89. Hyppönen E, Läärä E, Reunanen A, Jär–velin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet (2001) 358(9292):1500–3.10.1016/S0140-6736(01)06580-1 [PubMed] [CrossRef]
90. Cooper JD, Smyth DJ, Walker NM, Stevens H, Burren OS, Wallace C, et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes (2011) 60(5):1624–31.10.2337/db10-1656 [PMC free article] [PubMed] [CrossRef]
91. Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, et al. A promoter polymorphism of the CYP27B1 gene is associated with Addison’s disease, Hashimoto’s thyroiditis, Graves’ disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol (2004) 151(2):193–7.10.1530/eje.0.1510193 [PubMed] [CrossRef]
92. Pazderska A, Fichna M, Mitchell AL, Napier CM, Gan E, RuchaŁa M, et al. Impact of month of birth on the risk of development of autoimmune Addison’s disease. J Clin Endocrinol Metab (2016) 101(11):4214–8.10.1210/jc.2016-2392 [PMC free article] [PubMed] [CrossRef]
93. Giovinazzo S, Vicchio TM, Certo R, Alibrandi A, Palmieri O, Campennì A, et al. Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D3 levels in Hashimoto’s thyroiditis. Endocrine (2017) 55(2):599–606.10.1007/s12020-016-0942-5 [PubMed] [CrossRef]
94. Muscogiuri G, Tirabassi G, Bizzaro G, Orio F, Paschou SA, Vryonidou A, et al. Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr (2015) 69(3):291–6.10.1038/ejcn.2014.265 [PubMed] [CrossRef]
95. Ahn HY, Chung YJ, Cho BY. Serum 25-hydroxyvitamin D might be an independent prognostic factor for Graves disease recurrence. Medicine (Baltimore) (2017) 96(31):e7700.10.1097/MD.0000000000007700 [PMC free article] [PubMed] [CrossRef]
96. Xu MY, Cao B, Yin J, Wang DF, Chen KL, Lu QB. Vitamin D and Graves’ disease: a meta-ana–lysis update. Nutrients (2015) 7(5):3813–27.10.3390/nu7053813 [PMC free article] [PubMed] [CrossRef]
97. Bellastella G, Maiorino MI, Petrizzo M, De Bellis A, Capuano A, Esposito K, et al. Vitamin D and autoimmunity: what happens in autoimmune polyendocrine syndromes? J Endocrinol Invest (2015) 38(6):629–33.10.1007/s40618-014-0233-z [PubMed] [CrossRef]
98. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ (2017) 356:i6583.10.1136/bmj.i6583 [PMC free article][PubMed] [CrossRef]
99. Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, Zittermann A, et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) (2011) 75(5):575–84.10.1111/j.1365-2265.2011.04147.x [PubMed] [CrossRef]
100. Afzal S, Nordestgaard BG. Vitamin D, hypertension, and ischemic stroke in 116 655 individuals from the general population: a genetic study. Hypertension (2017) 70:499–507.10.1161/HYPERTENSIONAHA.117.09411 [PubMed] [CrossRef]
101. Juonala M, Voipio A, Pahkala K, Viikari JS, Mikkilä V, Kähönen M, et al. Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study. J Clin Endocrinol Metab (2015) 100(4):1469–76.10.1210/jc.2014-3944 [PubMed] [CrossRef]
102. Zittermann A, Ernst JB, Prokop S, Fuchs U, Dreier J, Kuhn J, et al. Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily. Eur Heart J (2017) 38(29):2279–86.10.1093/eurheartj/ehx235 [PubMed] [CrossRef]
103. Wu F, Juonala M, Pitkänen N, Jula A, Lehtimäki T, Sabin MA, et al. Both youth and long-term vitamin D status is associated with risk of type 2 diabetes mellitus in adulthood: a cohort study. Ann Med (2017) 7:1–9.10.1080/07853890.2017.1399446 [PubMed] [CrossRef]
104. Piantanida E, Gallo D, Veronesi G, Dozio E, Trotti E, Lai A, et al. Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role? Endocr Connect (2017) 6(8):943–51.10.1530/EC-17-0304 [PMC free article] [PubMed] [CrossRef]
105. Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. The effect of improved serum 25-hydroxyvitamin D status on glycemic control in diabetic patients: a meta-analysis. J Clin Endocrinol Metab (2017) 102(9):3097–110.10.1210/jc.2017-01024 [PubMed] [CrossRef]
106. Chu F, Ohinmaa A, Klarenbach S, Wong ZW, Veugelers P. Serum 25-hydroxyvitamin D concentrations and indicators of mental health: an analysis of the Canadian Health Measures Survey. Nutrients (2017) 9(10):E1116.10.3390/nu9101116 [PMC free article] [PubMed] [CrossRef]
107. Doğan Bulut S, Bulut S, Görkem Atalan D, Berkol T, Gürçay E, Türker T, et al. The relationship between symptom severity and low vitamin D le–vels in patients with schizophrenia. PLoS One (2016) 11(10):e0165284.10.1371/journal.pone.0165284 [PMC free article][PubMed] [CrossRef]
108. Endres D, Dersch R, Stich O, Buchwald A, Perlov E, Feige B, et al. Vitamin D deficiency in adult patients with schizophreniform and Autism Spectrum Syndromes: a one-year cohort study at a German tertiary care hospital. Front Psychiatry (2016) 7:168.10.3389/fpsyt.2016.00168 [PMC free article] [PubMed] [CrossRef]
109. Feart C, Helmer C, Merle B, Herrmann FR, Annweiler C, Dartigues JF, et al. Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer’s disease in older adults. Alzheimers Dement (2017) 13(11):1207–16.10.1016/j.jalz.2017.03.003 [PubMed] [CrossRef]
110. Grant WB. Vitamin D and incident dementia and cognitive impairment. Am J Clin Nutr (2017) 106(2):699–700.10.3945/ajcn.117.158568 [PubMed] [CrossRef]
111. Sommer I, Griebler U, Kien C, Auer S, Kle–rings I, Hammer R, et al. Vitamin D deficiency as a risk factor for dementia: a systematic review and meta-ana–lysis. BMC Geriatr (2017) 17(1):16.10.1186/s12877-016-0405-0 [PMC free article] [PubMed] [CrossRef]
112. Mokry LE, Ross S, Morris JA, Manousaki D, Forgetta V, Richards JB. Genetically decreased vitamin D and risk of Alzheimer disease. Neurology(2016) 87(24):2567–74.10.1212/WNL.0000000000003430 [PMC free article] [PubMed] [CrossRef]
113. Wood JM, Gupta S. Vitamin D and neurocognitive disorder due to Alzheimer’s disease: a review of the literature. Ann Clin Psychiatry (2015) 27(2):e1–7. [PubMed]
114. Annweiler C. Vitamin D-mentia: is vitamin D optional or essential for preventing late-life cognitive decline? J Am Geriatr Soc (2017) 65(10):2155–7.10.1111/jgs.15056 [PubMed] [CrossRef]
115. Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, et al. Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health (2014) 104(8):e43–50.10.2105/AJPH.2014.302034 [PMC free article] [PubMed] [CrossRef]
116. Sun YQ, Langhammer A, Skorpen F, Chen Y, Mai XM. Serum 25-hydroxyvitamin D level, chronic di–seases and all-cause mortality in a population-based prospective cohort: the HUNT Study. Norway BMJ Open (2017) 7(6):e017256.10.1136/bmjopen-2017-017256 [PMC free article][PubMed] [CrossRef]
117. Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, et al. Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One (2017) 12(2):e0170791.10.1371/journal.pone.0170791 [PMC free article] [PubMed] [CrossRef]
118. Quraishi SA, Bittner EA, Blum L, McCarthy CM, Bhan I, Camargo CA, Jr. Prospective study of vitamin D status at initiation of care in critically ill surgical patients and risk of 90-day mortality. Crit Care Med (2014) 42:1365–71.10.1097/CCM.0000000000000210 [PMC free article][PubMed] [CrossRef]
119. McNally JD, Nama N, O’Hearn K, Sampson M, Amrein K, Iliriani K, et al. Vitamin D deficiency in critically ill children: a systematic review and meta-analysis. Crit Care (2017) 21(1):287.10.1186/s13054-017-1875-y [PMC free article] [PubMed] [CrossRef]
120. Zapatero A, Dot I, Diaz Y, Gracia MP, Pérez-Terán P, Climent C, et al. Severe vitamin D deficiency upon admission in critically ill patients is related to acute kidney injury and a poor prognosis. Med Intensiva (2018) 42(4):216–24.10.1016/j.medin.2017.07.004 [PubMed] [CrossRef]
121. Helde-Frankling M, Höijer J, Bergqvist J, Björkhem-Bergman L. Vitamin D supplementation to palliative cancer patients shows positive effects on pain and infections-results from a matched case-control study. PLoS One (2017) 12(8):e0184208.10.1371/journal.pone.0184208 [PMC free article] [PubMed] [CrossRef]
122. Bolerazska B, Rabajdova M, Spakova I, Marekova M. Current knowledge on the active form of vitamin D synthesized in the skin and its effects on malignant melanoma. Neoplasma (2017) 64(1):1–12.10.4149/neo_2017_101 [PubMed] [CrossRef]
123. Grant WB, Boucher BJ. Randomized controlled trials of vitamin D and cancer incidence: a modeling study. PLoS One (2017) 12(5):e0176448.10.1371/journal.pone.0176448 [PMC free article] [PubMed] [CrossRef]
124. Grant WB, Boucher BJ, Bhattoa HP, Lahore H. Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol (2018) 177:266–9.10.1016/j.jsbmb.2017.08.009 [PubMed] [CrossRef]
125. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol (2014) 2(1):76–89.10.1016/S2213-8587(13)70165-7 [PubMed] [CrossRef]
126. Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol (2017) 5(12):986–1004.10.1016/S2213-8587(17)30357-1 [PubMed] [CrossRef]
127. Czech-Kowalska J, Dobrzanska A, Pleskaczynska A, Malinowska E, Gruszfeld D, Karczmarewicz E, et al. Vitamin D status in premature infants at term. Bone (2009) 45(Suppl 2):S107.10.1016/j.bone.2009.04.181 [CrossRef]
128. Lukaszkiewicz J, Prószyńska K, Lorenc RS, Ludwiczak H. Hepatic microsomal enzyme induction: treatment of vitamin D poisoning in a 7 month old baby. Br Med J (Clin Res Ed) (1987) 295(6607):1173.10.1136/bmj.295.6607.1173 [PMC free article] [PubMed] [CrossRef]
129. Lameris AL, Geesing CL, Hoenderop JG, Schreuder MF. Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome. J Pediatr Endocrinol Metab (2014) 27(7–8):757–61.10.1515/jpem-2013-0229 [PubMed] [CrossRef]
130. Bosch X. Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease. JAMA (1998) 279(7):532–4.10.1001/jama.279.7.532 [PubMed] [CrossRef]
131. Dinour D, Davidovits M, Aviner S, Ganon L, Michael L, Modan-Moses D, et al. Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake. Pediatr Nephrol (2015) 30(1):145–52.10.1007/s00467-014-2889-1 [PubMed] [CrossRef]
132. Tebben PJ, Milliner DS, Horst RL, Harris PC, Singh RJ, Wu Y, et al. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab (2012) 97(3):E423–7.10.1210/jc.2011-1935 [PMC free article] [PubMed] [CrossRef]
133. Schlingmann KP, Ruminska J, Kaufmann M, Dursun I, Patti M, Kranz B, et al. Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotranspor–ter 2A cause idiopathic infantile hypercalcemia. J Am Soc Nephrol (2016) 27(2):604–14.10.1681/ASN.2014101025 [PMC free article] [PubMed] [CrossRef]
134. Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol (2018) 175:125–35.10.1016/j.jsbmb.2017.01.021 [PubMed] [CrossRef]
135. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2011) 96(1):53–8.10.1210/jc.2010-2704 [PMC free article] [PubMed] [CrossRef]
136. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 96(7):1911–30.10.1210/jc.2011-0385 [PubMed] [CrossRef]
137. European Food Safety Authority (EFSA). Dietary reference values for vitamin D, EFSA panel on dietetic products, nutrition and allergies (NDA). EFSA J (2016) 14:145.
138. Robien K, Oppeneer SJ, Kelly JA, Hamilton-Reeves JM. Drug-vitamin D interactions: a systema–tic review of the literature. Nutr Clin Pract (2013) 28(2):194–208.10.1177/0884533612467824 [PMC free article] [PubMed] [CrossRef]
139. Arora E, Singh H, Gupta YK. Impact of antiepileptic drugs on bone health: need for monitoring, treatment, and prevention strategies. J Family Med Prim Care (2016) 5(2):248–53.10.4103/2249-4863.192338 [PMC free article] [PubMed] [CrossRef]
140. Fan HC, Lee HS, Chang KP, Lee YY, Lai HC, Hung PL, et al. The impact of anti-epileptic drugs on growth and bone metabolism. Int J Mol Sci(2016) 17(8):E1242.10.3390/ijms17081242 [PMC free article] [PubMed] [CrossRef]
141. Radlović N, Leković Z, Ristić D, Radlović V, Djuričić G, Dimitrijević A, et al. Case report of acute vitamin D intoxication in an infant. Srp Arh Celok Lek (2014) 142(11–12):736–9.10.2298/SARH1412736R [PubMed] [CrossRef]
142. Nordic Council of Ministers. Nordic Nutrition Recommendation 2012. Integrating Nutrition and Physical Activity. 5th ed Norden, Copenhagen, Denmark: (2012). Available from: https://www.norden.org/en/theme/nordic-nutrition-recommendation/nordic-nutrition-recommendations-2012(Accessed: January 15, 2018).
143. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr (2008) 88(2):491S–9S.10.1093/ajcn/88.2.491S [PubMed] [CrossRef]
144. Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating vitamin D3 and 25-hydroxyvitamin D in humans: an important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol (2007) 103(3–5):631–4.10.1016/j.jsbmb.2006.12.066 [PMC free article] [PubMed] [CrossRef]
145. Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res (2010) 25(2):305–12.10.1359/jbmr.090728 [PubMed] [CrossRef]
146. Hollis BW, Wagner CL. New insights into the vitamin D requirements during pregnancy. Bone Res (2017) 5:17030.10.1038/boneres.2017.30 [PMC free article] [PubMed] [CrossRef]
147. Hollis BW, Wagner CL. Vitamin D supplementation during pregnancy: improvements in birth outcomes and complications through direct genomic alteration. Mol Cell Endocrinol (2017) 453:113–30.10.1016/j.mce.2017.01.039 [PubMed] [CrossRef]
148. Wagner CL, Hollis BW, Kotsa K, Fakhoury H, Karras SN. Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications. Rev Endocr Metab Disord (2017) 18(3):307–22.10.1007/s11154-017-9414-3 [PubMed] [CrossRef]
149. Bouillon R. Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol (2017) 13(8):466–79.10.1038/nrendo.2017.31 [PubMed] [CrossRef]
150. Spedding S, Vanlint S, Morris H, Scragg R. Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? Nutrients (2013) 5(12):5127–39.10.3390/nu5125127 [PMC free article] [PubMed] [CrossRef]
151. Smith TJ, Tripkovic L, Damsgaard CT, Mølgaard C, Ritz C, Wilson-Barnes SL, et al. Estimation of the dietary requirement for vitamin D in adolescents aged 14–18 y: a dose-response, double-blind, rando–mized placebo-controlled trial. Am J Clin Nutr (2016) 104(5):1301–9.10.3945/ajcn.116.138065 [PubMed] [CrossRef]
152. Rajakumar K, Moore CG, Yabes J, Olabopo F, Haralam MA, Comer D, et al. Estimations of dietary vitamin D requirements in black and white children. Pediatr Res (2016) 80(1):14–20.10.1038/pr.2016.46 [PMC free article] [PubMed] [CrossRef]
153. Sacheck JM, Van Rompay MI, Chomitz VR, Economos CD, Eliasziw M, Goodman E, et al. Impact of three doses of vitamin D3 on serum 25(OH)D deficiency and insufficiency in at-risk schoolchildren. J Clin Endocrinol Metab (2017) 102(12):4496–505.10.1210/jc.2017-01179 [PMC free article] [PubMed] [CrossRef]
154. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ (2009) 339:b3692.10.1136/bmj.b3692 [PMC free article] [PubMed] [CrossRef]
155. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 367(1):40–9.10.1056/NEJMoa1109617 [PubMed] [CrossRef]
156. American Geriatrics Society Workgroup on Vitamin D Supplementation for Older Adults. Recommendations abstracted from the American Geriatrics Society Consensus Statement on vitamin D for prevention of falls and their consequences. J Am Geriatr Soc (2014) 62(1):147–52.10.1111/jgs.12631 [PubMed] [CrossRef]
157. Mathur NB, Saini A, Mishra TK. Assessment of adequacy of supplementation of vitamin D in very low birth weight preterm neonates: a randomized controlled trial. J Trop Pediatr (2016) 62(6):429–35.10.1093/tropej/fmv110 [PubMed] [CrossRef]
158. Fort P, Salas AA, Nicola T, Craig CM, Carlo WA, Ambalavanan N. A comparison of 3 vitamin D dosing regimens in extremely preterm infants: a randomized controlled trial. J Pediatr (2016) 174:132–8.e1.10.1016/j.jpeds.2016.03.028 [PMC free article] [PubMed] [CrossRef]
159. Bozkurt O, Uras N, Sari FN, Atay FY, Sahin S, Alkan AD, et al. Multi-dose vitamin d supplementation in stable very preterm infants: prospective randomized trial response to three different vitamin D supplementation doses. Early Hum Dev (2017) 112:54–9.10.1016/j.earlhumdev.2017.07.016 [PubMed] [CrossRef]
160. Cho SY, Park HK, Lee HJ. Efficacy and safety of early supplementation with 800 IU of vitamin D in very preterm infants followed by underlying levels of vitamin D at birth. Ital J Pediatr (2017) 43(1):45.10.1186/s13052-017-0361-0 [PMC free article] [PubMed] [CrossRef]
161. Czech-Kowalska J. Vitamin D in preterm infants. In: Watson RR, Mahadevan D, editors. Handbook of Nutrition and Diet in Therapy of Bone Diseases. Human Health Handbooks. The Netherlands: Wageningen Academic Publishers (2016). p. 233–46.
162. Monangi N, Slaughter JL, Dawodu A, Smith C, Akinbi HT. Vitamin D status of early preterm infants and the effects of vitamin D intake during hospital stay. Arch Dis Child Fetal Neonatal Ed (2014) 99(2):F166–8.10.1136/archdischild-2013-303999 [PMC free article] [PubMed] [CrossRef]
163. Abrams SA, Committee on Nutrition Calcium and vitamin d requirements of enterally fed preterm infants. Pediatrics (2013) 131(5):e1676–83.10.1542/peds.2013-0420 [PubMed] [CrossRef]
164. Czech-Kowalska J, Gruszfeld D, Jaworski M, Bulsiewicz D, Latka-Grot J, Pleskaczynska A, et al. Determinants of postpartum vitamin D status in the Caucasian mother-offspring pairs at a latitude of 52°N: a cross-sectional study. Ann Nutr Metab (2015) 67(1):33–41.10.1159/000437099 [PubMed] [CrossRef]
165. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab (2007) 92(9):3517–22.10.1210/jc.2007-0718 [PMC free article] [PubMed] [CrossRef]
166. De-Regil LM, Palacios C, Lombardo LK, Peña-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev (2016) 1:CD008873.10.1002/14651858.CD008873.pub3 [PubMed] [CrossRef]
167. Misiorowski W, Misiorowska J, Dębski R, GŁuszko P, TŁustochowicz W, Zgliczyński W. Stanowisko zespoŁu ekspertów w sprawie stosowania wysokich dawek witaminy D w zapobieganiu i leczeniu jej niedoboru. Medycyna Po Dyplomie. (Vol. 9). (2017). Available from: https://podyplomie.pl/medycyna/28499,stanowisko-zespolu-ekspertow-w-sprawie-stosowania-wysokich-dawek-witaminy-d-w-zapobieganiu-i(Accessed: January 20, 2018).
168. Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med (2016) 176(2):175–83.10.1001/jamainternmed.2015.7148 [PubMed] [CrossRef]
169. Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev (2015) 16(4):341–9.10.1111/obr.12239 [PubMed] [CrossRef]
170. Zittermann A, Ernst JB, Gummert JF, Börgermann J. Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a syste–matic review. Eur J Nutr (2014) 53(2):367–74.10.1007/s00394-013-0634-3 [PubMed] [CrossRef]
171. Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One (2014) 9(11):e111265.10.1371/journal.pone.0111265 [PMC free article] [PubMed] [CrossRef]
172. Drincic A, Fuller E, Heaney RP, Armas LA. 25-Hydroxyvitamin D response to graded vitamin D(3) supplementation among obese adults. J Clin Endocrinol Metab (2013) 98(12):4845–51.10.1210/jc.2012-4103 [PubMed] [CrossRef]

Similar articles

Microbiota in human life: review of modern literature
Authors: Матвієнко І.М.
ДУ «Інститут педіатрії, акушерства та гінекології НАМН України», м. Київ, Україна

"Child`s Health" Том 12, №8, 2017
Date: 2018.01.29
Categories: Pediatrics/Neonatology
Sections: Specialist manual
Diarrheal syndrome in children and adolescents: the features of pathogenetic therapy
Authors: Белоусова О.Ю.
Харьковская медицинская академия последипломного образования, г. Харьков, Украина

"Child`s Health" Том 13, Додаток 1, 2018 Дитяча гастроентерологія та нутриціологія
Date: 2018.05.25
Categories: Pediatrics/Neonatology
Sections: Specialist manual
Stratification of Perioperative Risk in Patients with Acute Abdominal Surgical Pathology
Authors: Кравец О.В., Клигуненко Е.Н., Ехалов В.В. - ГУ «Днепропетровская медицинская академия МЗ Украины», г. Днепр, Украина
"Emergency medicine" 6 (77) 2016
Date: 2016.11.22
Categories: Medicine of emergency
Sections: Clinical researches
The changes in lymphocyte populations in patients with colorectal cancer depending on the method of anesthesia during surgical treatment
Authors: Горкавый Е.А., Лесной И.И.
Национальный институт рака, г. Киев, Украина

"Emergency medicine" №1(96), 2019
Date: 2019.03.20
Categories: Medicine of emergency
Sections: Clinical researches

Back to issue